scholarly journals ENSURING ACCESS TO PAIN RELIEF AS HUMAN RIGHTS

2018 ◽  
Vol 5 (1) ◽  
pp. 10-18
Author(s):  
K. Shapoval-Deinega K. ◽  
A. Rokhanskiy ◽  
O. Riga ◽  
A. Penkov
Keyword(s):  
Chronic Pain ◽  
Palliative Care ◽  
Human Rights ◽  
Pain Relief ◽  
Professional Training ◽  
Pain Syndrome ◽  
Chronic Pain Management ◽  
Chronic Pain Syndrome ◽  
Long Time

ENSURING ACCESS TO PAIN RELIEF AS HUMAN RIGHTSK. Shapoval-Deinega, A. Rokhanskiy, O. Riga, A. PenkovThe article presents the results of a selective study on the access to anesthesia. It has been determined that in most cases the goal of chronic pain management has not been achieved for a long time, the expected level of successful anesthesia has not been achieved in 80-90% of those in need, anesthesia is prescribed formally (“any prescription is a good prescription”), without taking into account clinical recommendations and clinical guidelines, that is doctors do not adhere to the principles of the WHO regarding the prescription of analgesics, approved by the Order of the Ministry of Health No. 311 as of 15 April 2012 “On the approval and implementation of medical and technological documents for standardization of palliative care in chronic pain syndrome”. The authors believe that professional training of doctors requires changes regarding the quality of palliative care in accordance with WHO standards, wide implementation of modern scientific concepts of anesthesia in all areas of medical staff training.Key words: palliative care, anesthesia, human rights. ЗАБЕЗПЕЧЕННЯ ДОСТУПУ ДО ЗНЕБОЛЕННЯ ЯК ПРАВА ЛЮДИНИК. Шаповал-Дейнега, А. Роханський, О. Ріга, А. Пеньков У статті наведено результати вибіркового дослідження щодо забезпечення людини до знеболення. Визначено, що у більшості випадків не досягнута мета лікування хронічного больового синдрому протягом тривалого часу, не досягнуто очікуваного рівня успішного знеболення у 80–90 % осіб, що цього потребують, знеболення призначається формально («щось призначили – і гаразд»), без урахування клінічних рекомендацій та клінічних настанов, тобто лікарі не дотримуються принципів ВООЗ щодо призначення знеболюючих засобів, які містяться у наказі МОЗ № 311від 25.04.2012 "Про затвердження та впровадження медико-технологічних документів зі стандартизації паліативної медичної допомоги при хронічному больовому синдромі". Автори вважають, що ротребує змін фахова підготовка лікарів щодо якості надання паліативної допомоги відповідно до стандартів ВООЗ, широкої імплементації сучасних наукових уявлень про знеболення в усі ланки підготовки медичних працівників.Ключові слова: паліативна допомога, знеболення, права людини. ОБЕСПЕЧЕНИЕ ДОСТУПА К ОБЕЗБОЛИВАНИЮ КАК ПРАВО ЧЕЛОВЕКАК. Шаповал-Дейнега, А. Роханский, О. Рига, А. ПеньковВ статье приведены результаты выборочного исследования по обеспечению человека к обезболиванию. Определено, что в большинстве случаев не достигнута цель лечения хронического болевого синдрома в течение длительного времени, не достигнуто ожидаемого уровня успешного обезболивания в 80-90% лиц, нуждающихся, обезболивания назначается формально ( «что-то назначили - и ладно»), без учета клинических рекомендаций и клинических руководств, то есть врачи не соблюдают принципы ВОЗ по назначению обезболивающих средств, которые содержатся в приказе Минздрава № 311вид 25.04.2012 "Об утверждении и внедрении медико-технологических документов по стандартизации паллиативной медицинской помощи при хроническом болевом синдроме ". Авторы считают, что ротребуе изменений профессиональная подготовка врачей по качеству оказания паллиативной помощи в соответствии со стандартами ВОЗ, широкой имплементации современных научных представлений о обезболивания во все звенья подготовки медицинских работников.Ключевые слова: паллиативная помощь, обезболивание, права человека.

Experience of using Neurouridine® in various types of peripheral neuropathy

2021 ◽  
Vol 7-8 (217-218) ◽  
pp. 29-36
Author(s):  
Nazira Zharkinbekova ◽  
◽  
Aiganym Khamidulina ◽  
Zhazira Barat ◽  
Botagoz Rustemova ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Chronic Pain ◽  
Peripheral Neuropathy ◽  
Pain Assessment ◽  
Pain Syndrome ◽  
Symptomatic Therapy ◽  
Chronic Pain Syndrome ◽  
Combination Drug ◽  
Face Scale

The quality of life of patients with chronic pain syndrome remains one of the most pressing issues. Pain is considered chronic if it lasts or recurs for more than 3-6 months. This contributes to disability, depression, sleep disorders, poor quality of life, and what is important in this situation, the cost of treatment. According to statistics, the average prevalence of chronic pain in the adult population is 20%. Practitioners everywhere are in search of new methods of pain relief. Purpose of research. The quality of life of patients with chronic pain syndrome has traditionally remained a topical issue. Given the permanent nature of pain and the completeness of approaches to its relief, the modern Clinician is constantly looking for new treatment methods that meet the principles of evidence-based medicine and safety. Material and methods. This paper presents the results of using Neurouridine® in 30 patients with peripheral neuropathy. 30 patients were randomized for a 3-week treatment period. Average age: 47.5±1.5 years. All patients received standard symptomatic therapy, and an oral combination drug containing b vitamins, folic acid, choline, and Uridine was added to the treatment in the 150 mg mode once a day. Patients made three visits to the outpatient neurological office: visit 1-to evaluate pre-treatment, visit 2-after 10 days of treatment, and visit 3-after 20 days of treatment. Each patient was presented with two performance evaluations at each study visit: pain assessment on the CRS NRS scale, and the fps Face scale. Results and discussion. Analysis of the results of the treatment showed improvement in the form of reduced pain, improved quality of life in 65.90%, rapid recovery of performance in 32.10%, reduced need for analgesics in 59.90% and complete disappearance of symptoms in 25.30% of patients. Pain was assessed using the HI NRG scale, the AZA Face scale, and the frequency of analgesics at the patient's first, second, and third visits. Conclusion. The use of Neurouridine® for analgesic purposes has shown a positive effect on reducing symptoms in patients with peripheral neuropathy. The results confirm that this therapy provides a clear regeneration of the nerves, relieving pain, and reducing the soreness characteristic of nerve damage. Keyword: peripheral neuropathy, Neurouridine®, pain assessment, quality of life.

scholarly journals Bioregulatory drugs in osteoarthritis management

2019 ◽  
pp. 76-83
Author(s):  
O. A. Shavlovskaya
Keyword(s):  
Chronic Pain ◽  
Pain Relief ◽  
Combined Treatment ◽  
Pain Syndrome ◽  
Cartilage Destruction ◽  
Degenerative Joint Disease ◽  
Joint Disease ◽  
Functional Improvement ◽  
Chronic Pain Syndrome ◽  
Matrix Loss

Osteoarthritis (OA) is a degenerative joint disease. Modern theories consider various structural (cartilage destruction) and biophysical disorders (matrix loss of glycosaminoglycans) as the basis of acute and chronic pain syndrome. The main aim of OA therapy is pain relief and functional improvement. To manage pain syndrome in OA it is reasonable to use complex bioregulatory drugs (CBD) (Traumeel S, Zeel T, Discus compositum) both in monotherapy and in combined treatment. The effectiveness of CBD is comparable to that of NSAIDs and CS.

scholarly journals Electronic educational course for medical specialists training in diagnostics of chronic pain syndrome in adult patients requiring palliative care

2021 ◽  
Vol 16 (1) ◽  
Author(s):  
Nevzorova Diana ◽  
Prirodova Olga Fedorovna ◽  
Sidorov Alexander ◽  
Guzel Rafailovna Abuzarova ◽  
Oksana Yurievna Kudrina ◽  
...  
Keyword(s):  
Chronic Pain ◽  
Palliative Care ◽  
Pain Syndrome ◽  
Adult Patients ◽  
Chronic Pain Syndrome ◽  
Medical Specialists ◽  
Educational Course

scholarly journals KINESIOTAPE METHODOLOGY FOR CHRONIC PAIN SYNDROME IN THE LUMBOSACRAL REGION

2021 ◽  
Vol 27 (3) ◽  
pp. 3950-3954
Author(s):  
Stamenka Mitova ◽  
◽  
Mariya Gramatikova ◽  
Margarita Avramova ◽  
Georgi Stoyanov ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Chronic Pain ◽  
Pain Syndrome ◽  
Control Group ◽  
Life Questionnaire ◽  
Chronic Pain Syndrome ◽  
Lumbosacral Region ◽  
Before And After ◽  
Experimental Group

Purpose: The study aims to evaluate the effect of kinesiotape methodology on chronic pain syndrome in the lumbosacral region. Material and Methods: 42 participants with chronic low back pain were recruited and randomly divided into two groups – control (n=19) and experimental (n=23). Foreword and lateral tilt, Borg and Modified Merld’Aubigne Scale for pain were used for assessment before and after treatment. Roland-Morris Questionnaire was done to assess the quality of life before and three months after treatment. The participants received a specialized kinesitherapy program combined with kinesio tape daily for 15 days with a duration of 40 minutes per procedure. They all received a home kinesitherapy program. Data were analyzed using GraphPad prism 3.02. Results: 42 participants, including 20 women and 22 men, were examined. The mean age (X±SD) of the control group was 45±9.08years, and for experimental was49.13±8.3 years. Median values of the Borg pain scale were as follows: 7.53±0.84 before, and 6.05±0.78 after treatment for the control group and 7.39±0.99 and 4.61±0.78 for the experimental group. Merld’AubigneScaleshows before and after treatment for control group 4.26±065 and 3.12±0.49 respectively, while in experimental was 4.26±0.68 and 2.09±0.44 after treatment. The average of forwarding tilts measured before and after treatment was13.79±3.77cm and 10±3.6cm for the control group and 13.13±3.76 and 7.52±2.25 for the experimental group. Initially, the quality of life questionnaire shows 17.26±1.66 and three months later was 12±1.45 for the control group and 17.35±1.5 before, and descend to 9.00±1.04 for the experimental group. There were statistically significant differences before and after treatment (p <0.05). Conclusions: Treatment significantly reduces pain and muscle spasms after application and improves thefunctionality of the lumbar spine. Kinesiotape not only helps the reduction of pain symptoms in musculoskeletal pathologies but is also a valuable addition to the kinesitherapy procedures.

Efficacy of Self-hypnosis on Quality of Life For Children with Chronic Pain Syndrome

2018 ◽  
Vol 66 (1) ◽  
pp. 43-55 ◽  
Author(s):  
Honorine Delivet ◽  
Sophie Dugue ◽  
Alexis Ferrari ◽  
Silvia Postone ◽  
Souhayl Dahmani
Keyword(s):  
Quality Of Life ◽  
Chronic Pain ◽  
Pain Syndrome ◽  
Chronic Pain Syndrome

Duloxetine Added to Tramadol in Chronic Pain Syndrome

2016 ◽  
Vol 33 (S1) ◽  
pp. S500-S501
Author(s):  
M. Domijan ◽  
Z. Lončar ◽  
S. Udovičić
Keyword(s):  
Quality Of Life ◽  
Chronic Pain ◽  
Sleep Disturbances ◽  
Short Form ◽  
Pain Syndrome ◽  
Mcgill Pain Questionnaire ◽  
Chronic Pain Syndrome ◽  
Reduction Of Pain ◽  
Competing Interest

IntroductionAbout 15–20% of the population suffering from the chronic pain. Over time, chronic pain can result in different emotional problems, social isolation, sleep disturbances, which reduce the quality of life. Chronic pain syndrome (CPS) indicates persistent pain, subjective symptoms in excess of objective findings, associated dysfunctional pain behavious and self-limitation in activities of daily living. Duloxetine is a potent antidepressant approved by the Food and Drug Administration for the chronic musculoskeletal disorder, diabetic neuropathic pain, fibromyalgia, generallized anxiety disorder and major depressive disorder.ObjectiveTo determine the effect of duloxetine on the reduction of pain and psychosocial suffering.AimsThe goal of the treatment should be to effectively reduce pain while improving function and reducing psychosocial suffering.MethodsThirty-six adult, nondepressed patients, already on tramadol therapy were included. Patients with VAS (visual analogue scale) ≥ 4were treated with duloxetine for 13 weeks. We measured pain intensity with the McGill Pain Questionnaire-Short Form (MPQ-SF) and compared VAS before starting the treatment with duloxetine and weekly for 13 weeks.ResultsPain response was defined as a 30%decrease in the MPQ-SF. A total of 62.5% of the sample met these criteria for response. Among them, 13.8% of patients were discontinued because of adverse effects. Duloxetine significantly improved functioning and the quality of life in patients with CPS.ConclusionsBecause of it is analgesic properties, duloxetine in the lower antidepressant doses (60 mg taken ones daily) combined with tramadol (another analgesic agent) can be useful in CPS for patients who do not respond satisfactory to monotherapy.Disclosure of interestThe authors have not supplied their declaration of competing interest.

scholarly journals Neuropathic pain in rheumatoid arthritis

2020 ◽  
Vol 12 (5) ◽  
pp. 60-65
Author(s):  
E. S. Filatova ◽  
A. M. Lila ◽  
V. A. Parfenov
Keyword(s):  
Quality Of Life ◽  
Rheumatoid Arthritis ◽  
Chronic Pain ◽  
Nervous System ◽  
Neuropathic Pain ◽  
Pain Syndrome ◽  
Chronic Pain Syndrome ◽  
Paindetect Questionnaire ◽  
Somatosensory Nervous System

Objective: to identify the signs of neuropathic pain (NP) in patients with rheumatoid arthritis (RA) on the basis of the PainDETECT questionnaire and neurological examination.Patients and methods. A total of 208 RA patients (39 men and 169 women; mean age, 47.7 years) with chronic pain syndrome were examined. The patients underwent rheumatological and neurological examinations; NP was diagnosed using the PainDETECT questionnaire; inflammation severity (DAS28 index), pain intensity (VAS), affective disorders (HADS), and quality of life (EQ-5D) were assessed.Results and discussion. 172 (82.7%) patients had moderate and high disease activity according to the DAS28. The signs of possible and highly probable NP according to the PainDETECT questionnaire were detected in 29.8 and 26.9% of patients, respectively; they were significantly more likely to be detected in patients with more severe pain syndrome, clinically significant anxiety, and worse quality of life, but were unassociated with RA activity according to the DAS28. Somatosensory nervous system injury (polyneuropathy, tunnel syndromes, and cervical myelopathy) was found in 77.6% of patients with possible NP and in 80.4% with highly probable NP. In other patients, NP might be caused by central sensitization. Conclusion. In patients with a RA exacerbation, chronic pain syndrome is caused not only by an active inflammatory process in the joint area and adjacent tissues, but also by somatosensory nervous system injury and central sensitization.

Automation of the regional register of persons needing palliative medical care in Krasnodar region

2020 ◽  
pp. 6-14
Author(s):  
N. V. Kardashova ◽  
◽  
M. A. Korogod ◽  
A. A. Koshkarov ◽  
R. A. Murashko ◽  
...  
Keyword(s):  
Chronic Pain ◽  
Palliative Care ◽  
Medical Care ◽  
Pain Syndrome ◽  
Orphan Diseases ◽  
Chronic Pain Syndrome ◽  
Health Authorities ◽  
Public Health Authorities ◽  
Krasnodar Region ◽  
Palliative Medical Care

The relevance of improving the management of the palliative care system in the Krasnodar region, the direct provision of medical care and the interaction of public health authorities is due to the processing of large amounts of data on the need for pain relief and equipment. In each municipality of the Territory, registers of patients suffering from chronic pain syndrome are maintained. The purpose of the article is to develop a methodology for integration municipal registers into a single register of people needed palliative care, and automation of management at the regional level. The paper discusses approaches to create a unified database (registers) of patients suffering from chronic pain syndrome receiving palliative care in order to assess the compliance of medical care with modern clinical guidelines. The possibilities of a unified information system for extracting and dispensing preferential recipes for the implementation of the technology for automated management of the regional registry along with the registers of federal and regional beneficiaries, orphan diseases are shown.

Analysis of the assortment of narcotic drugs used for the treatment of pain in cancer patients in the palliative care unit

2021 ◽  
Vol 2 (88) ◽  
pp. 93-96
Author(s):  
N. V. Orlova ◽  
◽  
N.V. Abrosimova ◽  
Yu.A. Melnitskaya ◽  
I.V. Kryukova ◽  
...  
Keyword(s):  
Chronic Pain ◽  
Palliative Care ◽  
Cancer Patients ◽  
Pain Syndrome ◽  
Opioid Analgesics ◽  
Dosage Forms ◽  
Palliative Care Unit ◽  
Chronic Pain Syndrome ◽  
Oncological Center ◽  
Narcotic Drugs

A study of the assortment of narcotic drugs for the relief of acute and chronic pain syndrome in cancer patients in the palliative care unit of the Oncological Center was carried out. It has been shown that practically all registered dosage forms of opioid analgesics are used

Sign in / Sign up

Export Citation Format

Share Document